Effect of obesity on overall survival in patients diagnosed with chronic myelomonocytic leukemia (CMML)

被引：0
|
作者：
Alfakara, Dima
Swedeh, Amer
Kaufman, Gregory
Patnaik, Mrinal M.
Hashmi, Sharukh
Hogan, William J.
Elliott, Michelle A.
Wolanskyj, Alexandra P.
Liu, Shujun
Litzow, Mark Robert
Al-Kali, Aref
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7064
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Autoimmunity in Patients (pts) with Chronic Myelomonocytic Leukemia (CMML): A Frequent Finding
    Swedeh, Amer
    Patnaik, Mrinal
    Alfakara, Dima
    Ashrani, Aneel A.
    Pruthi, Rajiv
    Elliott, Michelle
    Litzow, Mark
    Al-Kali, Aref
    BLOOD, 2012, 120 (21)
  • [22] Eltrombopag Use in Chronic Myelomonocytic Leukemia (CMML) Patients: A Cautionary Tale
    Ramadan, Hanadi
    Duong, Vu H.
    Al Ali, Najla H.
    Padron, Eric
    Zhang, Ling
    Lancet, Jeffrey E.
    List, Alan F.
    Komrokji, Rarni S.
    BLOOD, 2015, 126 (23)
  • [23] Comorbidities Are Major Drivers of Overall Survival of Chronic Myelomonocytic Leukemia
    Broadbent, Tyson
    Tantravahi, Srinivas K.
    Ravulapati, Sowmya
    Ward, Morgan
    Asay, Alexandra
    Peddinti, Ananth
    Kunz, Isaac
    Shami, Paul J.
    Kovacsovics, Tibor
    Courdy, Samir
    Boucher, Ken
    Deininger, Michael W.
    BLOOD, 2018, 132
  • [24] PROGNOSTIC FACTORS IN ADULT CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
    FENAUX, P
    BEUSCART, R
    JOUET, JP
    BAUTERS, F
    BLUT, 1988, 56 (06): : C12 - C12
  • [25] A phase I study of lenalidomide in patients with chronic myelomonocytic leukemia (CMML) - AGMT_CMML-1
    Burgstaller, Sonja
    Stauder, Reinhard
    Kuehr, Thomas
    Lang, Alois
    Machherndl-Spandl, Sigrid
    Mayrbaeurl, Beate
    Noesslinger, Thomas
    Petzer, Andreas
    Valent, Peter
    Greil, Richard
    Thaler, Josef
    LEUKEMIA & LYMPHOMA, 2018, 59 (05) : 1121 - 1126
  • [26] CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) - A MYELODYSPLASTIC OR MYELOPROLIFERATIVE SYNDROME
    MICHAUX, JL
    MARTIAT, P
    LEUKEMIA & LYMPHOMA, 1993, 9 (1-2) : 35 - 41
  • [27] Oligomonocytic Chronic Myelomonocytic Leukemia (O-CMML) and Chronic Myelomonocytic Leukemia (CMML) Show Similar Clinical, Morphological, Immunophenotypic and Molecular Features
    Calvo, Xavier
    Garcia-Gisbert, Nieves
    Parraga, Ivonne
    Florensa, Lourdes
    Montesdeoca, Sara
    Fernandez, Concepcion
    Salido, Marta
    Puiggros, Anna
    Espinet, Blanca
    Bellosillo, Beatriz
    Colomo, Lluis
    Roman, David
    Andrade, Marcio
    Merchan, Brayan
    Ferrer, Ana
    Arenillas, Leonor
    BLOOD, 2019, 134
  • [28] Decitabine induces high response rates in patients with chronic myelomonocytic leukemia (CMML).
    Jabbour, Elias
    O'Brien, Susan
    Ravandi-Kashani, Farhad
    Cortes, Jorge
    Borthakur, Gautam
    Verstovsek, Srdan
    Garcia-Manero, Guillermo
    Giles, Francis
    Zanoria, Lourdes
    Davisson, Jan
    Issa, Jean-Pierre
    Kantarjian, Hagop M.
    BLOOD, 2006, 108 (11) : 750A - 750A
  • [29] CHARACTERISTICS, TREATMENT, OUTCOMES AND SURVIVAL OF IRISH PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKAEMIA (CMML)
    Maung, S.
    Burke, C.
    Bains, J.
    Coyne, M.
    Desmond, R.
    McHugh, J.
    Enright, H.
    HAEMATOLOGICA, 2015, 100 : 728 - 729
  • [30] IMPACT ON THE SURVIVAL OF PROLIFERATIVE TYPE MYELOMONOCYTIC LEUKEMIA DIAGNOSED PATIENTS
    de Gusmao, B. Moreno
    Perez-Persona, E.
    Guinea, J.
    Ardanaz, M.
    Mendizabal, A.
    Menchaca, C.
    Feliu, J.
    Calavia, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 561 - 561
12345